Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.0B | 12.6B | 14.1B | 12.2B |
Cost of revenue | -770M | 6.6B | 7.4B | 6.0B |
Gross profit | 1.8B | 6.1B | 6.8B | 6.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.1B | 2.8B | 3.3B | 3.3B |
Operating income | -90M | 440M | 620M | 20M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 30M | 830M | 840M | 710M |
Other income expense | — | — | — | — |
Pretax income | 40M | -340M | -160M | -600M |
Tax provision | -60M | -110M | -30M | -130M |
Net income | -390M | -240M | -140M | -480M |
Basic EPS | — | -0.5 | -0.3 | -1.0 |
Diluted EPS | — | -0.5 | -0.3 | -1.0 |
Basic average shares | — | 500M | 500M | 484.8M |
Diluted average shares | — | 500M | 500M | 484.8M |
EBITDA | 740M | 1.3B | 1.5B | 930M |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |